Beta Bionics Chief Product Officer Mike Mensinger sold 4,375 shares at $19.11 per share on September 2, 2026. His post-transaction holding was 180,040 shares, giving BBNX investors a specific view of the executive’s remaining stock position after the transaction.

Key Highlights

  • The shares were sold at $19.11 each.
  • Mike Mensinger owned 180,040 shares after the transaction.
  • The sale took place on September 2, 2026.

$19.11 Share Sale Leaves 180,040 Shares

The transaction involved the company’s product chief and left Mensinger with 180,040 shares afterward. Mike Mensinger serves as Chief Product Officer at Beta Bionics (NASDAQ: BBNX). The shares were sold at $19.11 per share. The transaction took place on September 2, 2026. Mensinger’s ownership following the sale stood at 180,040 shares.